Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / shareholder investigation halper sadeh llc investiga


TCRR - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI ADAP TCRR

NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Radius Global Infrastructure, Inc. (NASDAQ:RADI)'s sale to EQT Active Core Infrastructure and Public Sector Pension Investment Board for $15.00 per share in cash. If you are a Radius shareholder, click here to learn more about your rights and options.

Adaptimmune Therapeutics plc (NASDAQ:ADAP)'s merger with TCR² Therapeutics Inc. Under the terms of the agreement, TCR² stockholders will receive 1.5117 Adaptimmune ADS for each TCR² share. Following the closing of the transaction, Adaptimmune shareholders will own approximately 75% of the combined company. If you are a Adaptimmune shareholder, click here to learn more about your rights and options.

TCR² Therapeutics Inc. (NASDAQ:TCRR)'s sale to Adaptimmune Therapeutics plc for 1.5117 Adaptimmune ADS for each TCR² share is fair to TCR² shareholders. Following the closing of the transaction, TCR² stockholders will own approximately 25% of the combined company. If you are a TCR² shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLC



View source version on accesswire.com:
https://www.accesswire.com/747185/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-RADI-ADAP-TCRR

Stock Information

Company Name: TCR2 Therapeutics Inc.
Stock Symbol: TCRR
Market: NYSE
Website: tcr2.com

Menu

TCRR TCRR Quote TCRR Short TCRR News TCRR Articles TCRR Message Board
Get TCRR Alerts

News, Short Squeeze, Breakout and More Instantly...